Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants

Published:2016-08 Issue:36 Volume:34 Page:4304-4312
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Smith Alyson J.,Li Yufeng,Bazin Hélène G.,St-Jean Julien R.,Larocque Daniel,Evans Jay T.,Baldridge Jory R.

Funder

GlaxoSmithKline Biologicals SA

NIH

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Viral vaccines and CTL response;Woolard;J Biomed Biotechnol,2010

2. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis;Pliaka;Expert Rev Vaccines,2012

3. The safety evaluation of adjuvants during vaccine development: the AS04 experience;Garçon;Vaccine,2011

4. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity;Didierlaurent;J Immunol,2009

5. Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults;Chu;Vaccine,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica Nanoparticles;ACS Applied Bio Materials;2024-06-04

2. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation;Journal of Pharmacology and Experimental Therapeutics;2023-09-12

3. Peptide-based vaccine for cancer therapies;Frontiers in Immunology;2023-08-16

4. A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models;npj Vaccines;2023-07-24

5. Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses;Pharmaceutics;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3